• 1. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 2. Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 3. Institute of Health Data Science, Lanzhou University, Lanzhou 730000, P. R. China;
  • 4. Arthritis Clinic & Research Center, Peking University People's Hospital, Peking University, Beijing 100044, P. R. China;
  • 5. Department of Respiratory Medicine Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 401122, P. R. China;
  • 6. Center for Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou 510317, P. R. China;
  • 7. School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
  • 8. The Michael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton L8S4L8, Canada;
  • 9. Key Research Department of Standardization of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, P. R. China;
  • 10. Beijing Hospital of Traditional Chinese Medicine, Capital Medical University/Beijing Institute of Chinese Medicine/Beijing Evidence-based Chinese Medicine Center, Beijing 100010, P. R. China;
  • 11. Chinese Evidence-based Medicine Centre, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 12. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China;
  • 13. School of Public Administration and Policy, Health Technology Assessment and Policy Evaluation Group, Renmin University of China, Beijing 100872, P. R. China;
  • 14. Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, P. R. China;
  • 15. Editorial Office of Chinese Journal of Dermatology and International Journal of Dermatology and Vernereology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, P. R. China;
  • 16. China Center for Health Development Studies, Peking University, Beijing 100191, P. R. China;
  • 17. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, P. R. China;
  • 18. Department of Ophthalmology, Zhongshan Hospital Affiliated to Fudan University; Center for Evidence-based Medicine, Fudan University, Shanghai 200032, P. R. China;
  • 19. Xiamen Branch, Zhongshan Hospital Affiliated to Fudan University, Xiamen 361015, P. R. China;
  • 20. Department of Pulmonary and Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, P. R. China;
  • 21. Department of Orthopedic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, P. R. China;
  • 22. Department of General Surgery, the First Hospital of Lanzhou University, Lanzhou 730000, P. R. China;
  • 23. School of Nursing, Peking University, Beijing 100191, P. R. China;
CHEN Yaolong, Email: chenyaolong@lzu.edu.cn
Export PDF Favorites Scan Get Citation

Objective  The purpose of the extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines (RIGHT for INT) was to promote the development of comprehensive and clear article those introduced and interpreted clinical practice guidelines. Methods The RIGHT for INT checklist was developed following methods recommended by the EQUATOR Network. The development process included three stages. In the first stage, a multidisciplinary team of experts was recruited by email and WeChat and further divided into three groups (a steering group, a consensus group, and a secretariat group); in the second stage, the initial items were collected by literature review and brainstorming; and in the third stage, the final items were formed through a Delphi survey and expert consultation. Results A total of 40 initial items were collected through literature review and brainstorming. A final checklist of 27 items was formed after the Delphi survey and expert consultation. Conclusion The RIGHT for INT checklist provides guidance for guideline interpreters on how to introduce and interpret clinical practice guidelines in a scientific and comprehensive manner.

Citation: ZHOU Qi, XING Dan, LI Qinyuan, ZHANG Jingyi, LUO Xufei, YANG Nan, WANG Xiaoqin, YANG Kehu, TIAN Jinhui, LI Hui, LI Bo, CAI Yujia, JIN Yinghui, LV Lanting, SUN Feng, SHANG Shuxian, YUAN Beibei, LI Jiang, MA Bin, LI Xiuxia, YUAN Yuanzhi, WU Lei, WANG Bin, JIANG Lei, WANG Zhiwen, CHEN Yaolong, DU Liang. An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT. Chinese Journal of Evidence-Based Medicine, 2022, 22(5): 497-507. doi: 10.7507/1672-2531.202201137 Copy

  • Next Article

    Reporting guideline for systematic reviews of animal experiments in the field of traditional Chinese medicine